The ErbB oncogenic receptor tyrosine kinase family proteins (ErbB1, ErbB2, ErbB3, and ErbB4) have been shown to contribute significantly to pro-proliferation, migration, invasion, and drug resistance characteristics of diverse cancer cell types [55,56,57]. This evidence concerns the gene ERBB4 and cancer.